We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.05B
AUM Growth
+$688M
(+11%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
1,149
New
136
Increased
453
Reduced
359
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
| 2 |
Amazon
AMZN
|
+$35M |
| 3 |
TJX Companies
TJX
|
+$34.6M |
| 4 |
Phillips 66
PSX
|
+$33.1M |
| 5 |
Mastercard
MA
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.7M |
| 2 |
Cigna
CI
|
+$27.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 4 |
JPMorgan Chase
JPM
|
+$21M |
| 5 |
Marvell Technology
MRVL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 17.18% |
| 3 | Consumer Discretionary | 12.24% |
| 4 | Industrials | 11.66% |
| 5 | Healthcare | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
676
DELISTED
Marathon Oil Corporation
MRO
| $845K | 0.01% |
36,300
-6,700
| -16% | -$140K |
|
677
DTE Energy
DTE
$31.1B
| $840K | 0.01% |
9,048
-1,128
| -11% | -$105K |
|
678
First Merchants
FRME
$2.72B
| $836K | 0.01% |
18,572
+5,100
| +38% | +$243K |
|
679
Travere Therapeutics
TVTX
$5.33B
| $836K | 0.01% |
29,106
+1,376
| +5% | +$39.3K |
|
680
Thor Industries
THO
$3.99B
| $824K | 0.01% |
+9,840
| New | +$942K |
|
681
Photronics
PLAB
$1.79B
| $820K | 0.01% |
83,272
-65,741
| -44% | -$611K |
|
682
Vanda Pharmaceuticals
VNDA
$312M
| $818K | 0.01% |
35,625
-5,675
| -14% | -$116K |
|
|
MSGN
683
DELISTED
MSG Networks Inc.
MSGN
| $818K | 0.01% |
31,690
+10,700
| +51% | +$257K |
|
684
KALA BIO
KALA
$11.8M
| $806K | 0.01% |
+33
| New | +$1.01M |
|
|
GTS
685
DELISTED
Triple-S Management Corporation
GTS
| $806K | 0.01% |
+44,822
| New | +$1.19M |
|
|
FARO
686
DELISTED
Faro Technologies
FARO
| $805K | 0.01% |
12,510
-1,830
| -13% | -$117K |
|
|
VOXX
687
DELISTED
VOXX International Corporation Class A
VOXX
| $805K | 0.01% |
154,881
+26,473
| +21% | +$143K |
|
688
Financial Institutions
FISI
$800M
| $804K | 0.01% |
25,595
+4,500
| +21% | +$146K |
|
689
Strategic Education
STRA
$1.71B
| $794K | 0.01% |
5,797
+3,077
| +113% | +$395K |
|
|
SREV
690
DELISTED
ServiceSource International, Inc.
SREV
| $792K | 0.01% |
277,738
+46,341
| +20% | +$154K |
|
691
Wendy's
WEN
$1.33B
| $790K | 0.01% |
46,100
-45,400
| -50% | -$793K |
|
|
LEAF
692
DELISTED
Leaf Group Ltd.
LEAF
| $783K | 0.01% |
78,294
+52,279
| +201% | +$568K |
|
693
Advanced Energy
AEIS
$12.2B
| $771K | 0.01% |
+14,930
| New | +$864K |
|
|
SPR
694
DELISTED
Spirit AeroSystems
SPR
| $768K | 0.01% |
+8,380
| New | +$737K |
|
|
NPTN
695
DELISTED
NEOPHOTONICS CORP
NPTN
| $764K | 0.01% |
92,100
-15,100
| -14% | -$115K |
|
696
Selective Insurance
SIGI
$5.74B
| $760K | 0.01% |
11,968
+5,490
| +85% | +$337K |
|
|
FPRX
697
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $758K | 0.01% |
54,447
+10,457
| +24% | +$156K |
|
|
DENN
698
DELISTED
Denny's
DENN
| $757K | 0.01% |
+51,400
| New | +$777K |
|
|
RDC
699
DELISTED
Rowan Companies Plc
RDC
| $757K | 0.01% |
+40,200
| New | +$602K |
|
700
Amplify Energy
AMPY
$163M
| $745K | 0.01% |
83,651
+14,800
| +21% | +$175K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Jacobs Levy Equity Management held 1,149 positions worth $7.05B, up 11% from $6.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $306M of net new capital in Q3 2018, opening 136 new positions and adding to 453 existing holdings. Its largest new stake was TJX Companies: 673,440 shares worth $37.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $31.7M trimmed.
- Jacobs Levy Equity Management's largest Q3 2018 buy was TJX Companies: 673,440 shares worth $37.7M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q3 2018, an estimated $40.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $31.7M.
- Jacobs Levy Equity Management fully exited Dun & Bradstreet in Q3 2018, selling an estimated $17.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $7.05B portfolio in Q3 2018.
- Jacobs Levy Equity Management opened 136 new positions and closed 174 in Q3 2018.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $7.05B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.